AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,580 | +3.7% | 18,275 | +5.9% | 0.00% | – |
| Q2 2023 | $41,055 | +31.8% | 17,250 | +1.9% | 0.00% | – |
| Q1 2023 | $31,142 | -3.2% | 16,925 | 0.0% | 0.00% | – |
| Q4 2022 | $32,158 | +3115.8% | 16,925 | +3285.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | – | 500 | +900.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 50 | -50.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -97.1% | 100 | -98.3% | 0.00% | – |
| Q1 2021 | $34,000 | -26.1% | 5,850 | +14.7% | 0.00% | – |
| Q4 2020 | $46,000 | -20.7% | 5,100 | +2.0% | 0.00% | – |
| Q3 2020 | $58,000 | -51.7% | 5,000 | -33.3% | 0.00% | – |
| Q2 2020 | $120,000 | +160.9% | 7,500 | -8.5% | 0.00% | – |
| Q1 2020 | $46,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,300,000 | $17,160,000 | 2.55% |
| Alphabet Inc. | 699,352 | $9,231,000 | 0.56% |
| DAFNA Capital Management LLC | 100,000 | $1,320,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 705,356 | $9,311,000 | 0.29% |
| Artal Group S.A. | 500,000 | $6,600,000 | 0.26% |
| Cormorant Asset Management, LP | 479,988 | $6,336,000 | 0.25% |
| MPM BioImpact LLC | 39,740 | $525,000 | 0.19% |
| Granahan Investment Management | 305,158 | $4,028,000 | 0.18% |
| Burrage Capital Management LLC | 13,113 | $173,000 | 0.12% |
| Vident Investment Advisory, LLC | 118,866 | $1,569,000 | 0.10% |